We also recently reported that tubastatin A, an HDAC6‐specific inhibitor, could increase CSE acetylation and enhance its protein levels and H2S production, thereby helping to attenuate the vasoconstriction and hypertension induced by AngII.20 Here, HDAC6 is linked to hypertensive disorder.